| People In The News |
GenomeWeb Daily NewsPerkinElmer has tapped Peter Barrett, currently a partner at Atlas Venture, to serve on its board of directors. Barrett was a co-founder, executive VP and chief business officer at Celera Genomics, and in the 1980s and 1990s he held senior management ...
|
| PerkinElmer Passes This Key Test |
DailyFinanceBy Seth Jayson, The Motley Fool Posted 10:05AM 02/08/12 Investing There's no foolproof way to know the future for PerkinElmer (NYS: PKI) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before ...
|
| PerkinElmer Passes This Key Test |
Motley FoolBy Seth Jayson | More Articles There's no foolproof way to know the future for PerkinElmer (NYSE: PKI ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
|
| PerkinElmer launches new AlphaLISA Epigenetic Cellular Detection Kits |
News-Medical.netAt the 1 st annual Society for Laboratory Automation and Screening Conference in San Diego, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of four new cellular ...
|
| Luminex's Q4 Revenues Climb 16 Percent on Strong Assay Sales |
GenomeWeb Daily NewsIn this video, we speak with Todd Smith, senior leader of research and applications of PerkinElmer, and researchers from Stockholm University on accelerating the GROMACS molecular dynamics software suite with GPUs and CPUs. The Basu research group is ...
|
| PerkinElmer Expands Reagent Portfolio for Faster Identification of Epigenetic ... |
EON: Enhanced Online News (press release)SAN DIEGO--(EON: Enhanced Online News)--At the 1 st annual Society for Laboratory Automation and Screening Conference in San Diego, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, ...
|
| TheStreet Ratings Top 10 Rating Changes |
TheStreet.comPerkinElmer Inc (PKI) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and expanding profit margins.
|
